21 November 2018

Paul Scheepers has been invited as contributing author to the flagship Report “Science for Disaster Risk Management 2020 -  Acting today, Protecting Tomorrow”.

Report “Science for Disaster Risk Management 2020 -  Acting today, Protecting Tomorrow”.
This EU report is prepared by the Disaster Risk Management Knowledge Centre (DRMKC) at the Joint Research Centre, the scientific service of the European Commission. His contribution will address the hazards and related vulnerability that mostly threat human lives in the EU, either by death, injury or other health damage.
Paul Scheepers was invited based on several publications on the use of human biological monitoring in response to chemical incidents. His publications supported the decision of the federal government in Belgium to initiate a human biomonitoring study in the aftermath of the train crash in Wetteren. The use of biomarkers in the disaster risk management setting is considered an important innovative methodology that will support human health risk assessment during the aftermath of a disaster.
This authorship will complement his involvement as rapid risk assessment expert on chemical threats for the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) of DG Health and Food Safety that is mandated by the European Commission to provide within a short time-frame (36 hours) public health risk assessment in case of cross-border chemical threats in the European Union.

 
  • Want to know more about these subjects? Click on the buttons below for more news.

    RIHSHealth Evidence

Related news items


Large AI project receives over €95 million for ten years of public-private research

23 September 2021

Radboud university medical center (Radboudumc) participates in the ROBUST consortium, which consists of 17 AI labs, eight of which are dedicated to healthcare. Radboud university medical center leads five of these eight labs.

read more

Reading ADP-ribosylation signaling using chemical biology and interaction proteomics published in Molecular Cell

22 September 2021

Kasia Kliza and Michiel Vermeulen worked on a project to synthesize biotinylated ADPr-based probes that can identify ADPr readers and determine their specificity for mono- and polyADPr. They published this in Molecular Cell.

read more

Systematic analysis of short tandem repeats in 38,095 exomes provides an additional diagnostic yield

22 September 2021

Christian Gilissen and colleagues published in Genetics in Medicine about their work guiding the application of short tandem repeat analysis in clinical exome sequencing.

read more

TropIQ seeks new mosquito repellents

21 September 2021

TropIQ Health Sciences, a Radboudumc spin-off, has received a 1.3 million USD grant from the Bill & Melinda Gates Foundation to track down new mosquito repellents.

read more

New start-up Patholyt will bring AI research into pathology diagnostics

21 September 2021

Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research.

read more

Treatment of most common skin cancer can sometimes wait

20 September 2021

Not treating but keeping an eye on the cancer is also an option

read more